These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

860 related items for PubMed ID: 29181846

  • 1. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
    Yan G, Ru Y, Wu K, Yan F, Wang Q, Wang J, Pan T, Zhang M, Han H, Li X, Zou L.
    Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
    [Abstract] [Full Text] [Related]

  • 2. Ribosomal protein L22-like1 promotes prostate cancer progression by activating PI3K/Akt/mTOR signalling pathway.
    Yi X, Zhang C, Liu B, Gao G, Tang Y, Lu Y, Pan Z, Wang G, Feng W.
    J Cell Mol Med; 2023 Feb; 27(3):403-411. PubMed ID: 36625246
    [Abstract] [Full Text] [Related]

  • 3. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X, Xu X, He XF, Yuan Y, Chen C, Shen XY, Su S, Chen Z, Xu ST, Huang YH.
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [Abstract] [Full Text] [Related]

  • 4. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
    Liang F, Yue J, Wang J, Zhang L, Fan R, Zhang H, Zhang Q.
    Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
    [Abstract] [Full Text] [Related]

  • 5. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J, Feng L, Tian C, Tang YL, Tang Y, Hu FQ.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [Abstract] [Full Text] [Related]

  • 6. PSMC4 promotes prostate carcinoma progression by regulating the CBX3-EGFR-PI3K-AKT-mTOR pathway.
    Liu K, Zhang S, Gong Y, Zhu P, Shen W, Zhang Q.
    J Cell Mol Med; 2023 Aug; 27(16):2437-2447. PubMed ID: 37436074
    [Abstract] [Full Text] [Related]

  • 7. Zingerone suppresses cell proliferation via inducing cellular apoptosis and inhibition of the PI3K/AKT/mTOR signaling pathway in human prostate cancer PC-3 cells.
    Qian S, Fang H, Zheng L, Liu M.
    J Biochem Mol Toxicol; 2021 Jan; 35(1):e22611. PubMed ID: 32905641
    [Abstract] [Full Text] [Related]

  • 8. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M, Xu J, Siddiqui J, Feng F, Sun Y.
    Mol Cancer; 2016 Dec 12; 15(1):81. PubMed ID: 27955654
    [Abstract] [Full Text] [Related]

  • 9. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H, Liu Q, Tang J, Xie Y, Xu X, Huang R, Zhang Y, Jin K, Sun B.
    Cell Physiol Biochem; 2017 Dec 12; 41(6):2289-2306. PubMed ID: 28456796
    [Abstract] [Full Text] [Related]

  • 10. Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα.
    Talesa VN, Ferri I, Bellezza G, Love HD, Sidoni A, Antognelli C.
    Prostate; 2017 Feb 12; 77(2):196-210. PubMed ID: 27696457
    [Abstract] [Full Text] [Related]

  • 11. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y, Li L, Huang M, Duan C, Zhang L, Chen J.
    Cell Signal; 2014 Dec 12; 26(12):2782-92. PubMed ID: 25193113
    [Abstract] [Full Text] [Related]

  • 12. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway.
    Ou X, Zhang GT, Xu Z, Chen JS, Xie Y, Liu JK, Liu XP.
    Pathol Oncol Res; 2019 Apr 12; 25(2):635-646. PubMed ID: 30411297
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways.
    Gu Z, You Z, Yang Y, Ding R, Wang M, Pu J, Chen J.
    Bioengineered; 2021 Dec 12; 12(1):4719-4735. PubMed ID: 34338146
    [Abstract] [Full Text] [Related]

  • 14. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
    Xu S, Ge J, Zhang Z, Zhou W.
    Biomed Pharmacother; 2017 Dec 12; 96():634-641. PubMed ID: 29035829
    [Abstract] [Full Text] [Related]

  • 15. MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling.
    Yan G, Ru Y, Yan F, Xiong X, Hu W, Pan T, Sun J, Zhang C, Wang Q, Li X.
    Cell Commun Signal; 2019 May 15; 17(1):44. PubMed ID: 31092266
    [Abstract] [Full Text] [Related]

  • 16. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H, Zhang J, Zhang Y, Feng Q, Wang H, Li G, Jiang W, Li X.
    Gene; 2019 May 25; 698():50-60. PubMed ID: 30822475
    [Abstract] [Full Text] [Related]

  • 17. EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway.
    Fan HT, Shi YY, Lin Y, Yang XP.
    Eur Rev Med Pharmacol Sci; 2019 Sep 25; 23(18):7808-7815. PubMed ID: 31599405
    [Abstract] [Full Text] [Related]

  • 18. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z.
    Tissue Cell; 2022 Aug 25; 77():101817. PubMed ID: 35679685
    [Abstract] [Full Text] [Related]

  • 19. GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in Prostate Cancer.
    Qin X, Liu L, Li Y, Luo H, Chen H, Weng X.
    Technol Cancer Res Treat; 2023 Aug 25; 22():15330338231153618. PubMed ID: 36999196
    [Abstract] [Full Text] [Related]

  • 20. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
    Huang Y, Feng G, Cai J, Peng Q, Yang Z, Yan C, Yang L, Wang Z.
    Life Sci; 2020 May 01; 248():117449. PubMed ID: 32088212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.